Tolerability and safety of the intravenous immunoglobulin octagam ® 10% in patients with immune thrombocytopenia: a post-authorisation safety analysis of two non-interventional phase IV trials
Wietek, Stefan, Svorc, Daniel, Debes, Anette, Svae, Tor-EinarLanguage:
english
Journal:
Hematology
DOI:
10.1080/10245332.2017.1385892
Date:
October, 2017
File:
PDF, 1007 KB
english, 2017